9 Meters Biopharma Inc. (INNT) Stock Price & Overview
NASDAQ:INNT
Current stock price
The current stock price of INNT is 0.56 null. Today INNT is down by -20.23%. In the past month the price increased by 19.15%. In the past year, price decreased by -64.33%.
INNT Key Statistics
- Market Cap
- 23.142M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -0.60
- Dividend Yield
- N/A
INNT Stock Performance
INNT Stock Chart
INNT Technical Analysis
ChartMill assigns a technical rating of 4 / 10 to INNT. When comparing the yearly performance of all stocks, INNT is a bad performer in the overall market: 85.55% of all stocks are doing better.
INNT Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to INNT. INNT has a bad profitability rating. Also its financial health evaluation is rather negative.
INNT Earnings
INNT Forecast & Estimates
INNT Financial Highlights
Over the last trailing twelve months INNT reported a non-GAAP Earnings per Share(EPS) of -0.6. The EPS increased by 91.25% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -510.66% | ||
| ROE | N/A | ||
| Debt/Equity | 0 |
INNT Ownership
About INNT
Company Profile
Innovate Biopharmaceuticals, Inc. is a clinical stage biotechnology company. It focused on developing novel medicines for autoimmune/ inflammatory disease. The company's pipeline includes drug candidates for celiac disease, an unmet need, and ulcerative colitis. Its products includes INN-202 for the treatment of Celiac Disease with fast track designation, INN-108 for Inflammatory Bowel Disorders, mild to moderate Ulcerative Colitis and a GI orphan disease in a convenient liquid formulation, INN-329 for Magnetic Resonance Cholangiopancreatography which are in clinical stages. Innovate Biopharmaceuticals Inc., formerly known as Monster Digital, Inc., is based in SIMI VALLEY, United States.
Company Info
9 Meters Biopharma Inc.
8480 HONEYCUTT ROAD SUITE 120
RALEIGH NC 27615
CEO: Sandeep Laumas
Phone: 919-275-1933
9 Meters Biopharma Inc. / INNT FAQ
What does INNT do?
Innovate Biopharmaceuticals, Inc. is a clinical stage biotechnology company. It focused on developing novel medicines for autoimmune/ inflammatory disease. The company's pipeline includes drug candidates for celiac disease, an unmet need, and ulcerative colitis. Its products includes INN-202 for the treatment of Celiac Disease with fast track designation, INN-108 for Inflammatory Bowel Disorders, mild to moderate Ulcerative Colitis and a GI orphan disease in a convenient liquid formulation, INN-329 for Magnetic Resonance Cholangiopancreatography which are in clinical stages. Innovate Biopharmaceuticals Inc., formerly known as Monster Digital, Inc., is based in SIMI VALLEY, United States.
Can you provide the latest stock price for 9 Meters Biopharma Inc.?
The current stock price of INNT is 0.56 null. The price decreased by -20.23% in the last trading session.
Does 9 Meters Biopharma Inc. pay dividends?
INNT does not pay a dividend.
How is the ChartMill rating for 9 Meters Biopharma Inc.?
INNT has a ChartMill Technical rating of 4 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
What is 9 Meters Biopharma Inc. worth?
9 Meters Biopharma Inc. (INNT) has a market capitalization of 23.14M null. This makes INNT a Nano Cap stock.